Diagnosing Natriuretic Peptide Deficiency

Summary

Diagnosing Natriuretic Peptide Deficiency is a clinical trial^[1].

Key Facts

• Diagnosing Natriuretic Peptide Deficiency is in the country of United States^[2].
• Diagnosing Natriuretic Peptide Deficiency's instance of is recorded as clinical trial^[3].
• Diagnosing Natriuretic Peptide Deficiency's start time is recorded as +2017-01-01T00:00:00Z^[4].
• Diagnosing Natriuretic Peptide Deficiency's end time is recorded as +2017-06-08T00:00:00Z^[5].
• Diagnosing Natriuretic Peptide Deficiency's sponsor is recorded as Vanderbilt University Medical Center^[6].
• Diagnosing Natriuretic Peptide Deficiency's number of participants is recorded as {'unit': '1', 'amount': '+10'}^[7].
• Diagnosing Natriuretic Peptide Deficiency's title is recorded as Diagnosing Natriuretic Peptide Deficiency: A Pilot Study^[8].
• Diagnosing Natriuretic Peptide Deficiency's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[9].
• Diagnosing Natriuretic Peptide Deficiency's ClinicalTrials.gov ID is recorded as NCT03035929^[10].
• Diagnosing Natriuretic Peptide Deficiency's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+50'}^[11].
• Diagnosing Natriuretic Peptide Deficiency's research intervention is recorded as (RS)-cyclophosphamide^[12].
• Diagnosing Natriuretic Peptide Deficiency's clinical trial phase is recorded as phase I clinical trial^[13].
• Diagnosing Natriuretic Peptide Deficiency's research site is recorded as Vanderbilt University Medical Center^[14].
• Diagnosing Natriuretic Peptide Deficiency's principal investigator is recorded as Katherine Neubecker Bachmann^[15].
• Diagnosing Natriuretic Peptide Deficiency's study type is recorded as interventional study^[16].